Change 5-day change 1-year change 3-year change Capi.($)
-.--%+3.58% - - 0
+1.26%-2.30%+37.82%+113.76% 1,019B
+0.73%-6.31%+35.06%+62.14% 610B
+0.35%+0.15%+14.01%+80.87% 470B
+1.72%-4.54%+59.14%+37.01% 344B
+0.26%-1.58%+21.97%+41.79% 336B
+0.60%-3.48%+11.37%+34.33% 266B
+1.65%-4.27%-5.47%+9.69% 241B
-0.09%-3.71%+35.15%+51.88% 218B
-0.28%-5.24%+27.99%+93.08% 179B
Average +0.37%-3.63%+26.34%+58.28% 409.2B
Weighted average by Cap. +0.34%-3.51%+29.49%+70.06%
Logo Shire PLC
Shire specializes in developing, producing, and marketing pharmaceutical products for the treatment of nervous system dysfunctions (hyperactivity, epilepsy, Alzheimer's disease, etc.), cancer, gastro-intestinal illnesses, and infectious diseases. Net sales break down by source of income as follows: - sales of products (95.3%); - other (4.7%): primarily franchise royalties. Net sales break down geographically as follows: the United States (63.6%), Ireland (0.4%) and other (36%).
Employees
-